Holen Sie sich die Stockscreener-App
2.30
0.00%
0.00
Vorhandelsmarkt:
2.40
0.10
+4.35%
Schlusskurs vom Vortag:
$2.30
Offen:
$2.3
24-Stunden-Volumen:
2.64M
Relative Volume:
0.68
Marktkapitalisierung:
$356.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-110.78M
KGV:
-2.1495
EPS:
-1.07
Netto-Cashflow:
$-75.59M
1W Leistung:
+0.88%
1M Leistung:
-0.43%
6M Leistung:
-49.89%
1J Leistung:
-72.46%
1-Tages-Spanne:
$2.28
$2.395
1-Wochen-Bereich:
$2.28
$2.48
52-Wochen-Spanne:
$1.15
$9.79
Humacyte Inc Stock (HUMA) Company Profile
Firmenname
Humacyte Inc
Sektor
Branche
Telefon
919-313-9633
Adresse
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Vergleichen Sie HUMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.30 | 353.67M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-20 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-14 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Herabstufung | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Eingeleitet | Cowen | Outperform |
| 2021-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2021-09-22 | Eingeleitet | BTIG Research | Buy |
| 2021-09-16 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Humacyte Inc Aktie (HUMA) Neueste Nachrichten
What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com
What drives Humacyte Inc. stock priceMassive wealth growth - jammulinksnews.com
Is Humacyte Inc. Equity Warrant a good long term investmentFree Stock Index Interpretation - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com
Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com
What analysts say about Humacyte Inc. Equity Warrant stockConsistently profitable trades - jammulinksnews.com
What drives Humacyte Inc. Equity Warrant stock priceFree Stock Selection - Autocar Professional
Humacyte Inc. Equity Warrant Stock Analysis and ForecastTriple-digit wealth increases - Autocar Professional
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - MSN
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders - ACCESS Newswire
Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026 - MSN
Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today - MSN
Lobbying Update: $10,000 of HUMACYTE lobbying was just disclosed - Nasdaq
Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
Positive week for Humacyte, Inc. (NASDAQ:HUMA) institutional investors who lost 56% over the past year - simplywall.st
Humacyte's Symvess ECAT Listing: A Strategic Catalyst for Biotech's Comeback - AInvest
Humacyte’s Symvess gains DOD electronic catalog listing approval By Investing.com - Investing.com South Africa
Humacyte's Symvess ECAT Approval: A Strategic Play for Dominance in Vascular Trauma and Beyond - AInvest
Humacyte stock soars after Symvess gains DOD electronic catalog listing By Investing.com - Investing.com India
Humacyte stock soars after Symvess gains DOD electronic catalog listing - Investing.com Australia
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday - inkl
Humacyte stock up on ECAT listing for Symvess (HUMA:NASDAQ) - Seeking Alpha
Humacyte Announces Symvess ECAT Approval from U.S. Defense Logistics Agency - MarketScreener
Humacyte's Symvess Approved for Listing in US Defense Logistics Agency's Electronic Catalog - MarketScreener
Humacyte’s Symvess gains DOD electronic catalog listing approval - Investing.com
Military Healthcare Win: Humacyte's Symvess Now Approved for Defense and Veterans Affairs Facilities - Stock Titan
Finanzdaten der Humacyte Inc-Aktie (HUMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):